NY-THE-BODY-SHOP
9.1.2023 07:16:30 CET | Business Wire | Press release
Today is No Say Day - the last day in 2023 when young people’s voices are represented in parliaments around the world. This falls a week before world leaders and businesses gather in Davos for the World Economic Forum Annual Meeting. Often criticised for being out of touch, Davos is a prime example of the need for more youth voices in decision making spaces.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230108005001/en/
Antonia Tony-Fadipe, Inclusive Hiring Lead and The Body Shop Youth Collective member; Urvasi De Biasi, Activism Policy and Partnerships, The Body Shop; Lily Cannon, Activism Communications Manager, The Body Shop; Lucila San Martin, Global Activism Manager, The Body Shop (Photo: Business Wire)
Half of the world’s population is under 30, compared to just 2.6% of parliamentarians globally*. If this ratio were reflected in a year, youth voices would effectively go unheard after today. Just nine days into 2023, No Say Day is a stark demonstration of the fact that millions of young voices are excluded from decision-making spaces at a time when the world is facing extreme systemic challenges.
No Say Day is being marked as part of the Be Seen Be Heard campaign, led by The Body Shop in collaboration with the Office of the United Nations Secretary-General's Envoy on Youth to raise the voices of millions of young people in over 75 countries across six continents.
Public opinion is widely in favour of fairer political representation for young people. According to The Body Shop’s largest-ever global survey**, two thirds of people agree that the age balance in politics is wrong.
People across all age groups agree that political systems would be improved by giving young people a say in policy development. Young people are optimistic and determined to increase their involvement in public life. A third of those under age 30 surveyed would consider running for office, versus only a fifth of those over age 30.
Chris Davis, Global Sustainability and Activism Director at The Body Shop, said: “From climate change to economic instability and conflict, the world’s problems are too great to fall back on business-as-usual. Young people are energetic, thoughtful, and positive about the future – so it’s important their voices are seen and heard in parliaments around the world every day. This is clearly the preference of the public, who support a fairer approach to youth representation and trust young people’s views on the major issues of today.
“As world leaders and captains of industry gather in Davos next week, I urge them to work with young people to develop solutions to the problems we all face. Let’s make today the last No Say Day in our history.”
Jayathma Wickramanayake, the UN Secretary-General’s Envoy on Youth, said: “Young people are the experts of their own realities, and young people all over the world are making a difference every day by tackling issues that matter most to them. The idea that young people are change makers is not just a marketing campaign, it is a fact. We must dispel the myths surrounding young people, that they are irresponsible, disengaged, troublemakers, or do not have the experience to create real impact. Even in the most adverse of circumstances we have seen young people rising to the challenge and leading the way — from humanitarian crises to COVID-19 response. There is no doubt that we need young people’s innovation, drive, creativity and – more than anything – unwavering optimism that a better world is possible for everyone.”
ENDS
*https://www.ipu.org/our-impact/youth-empowerment/data-youth-participation
**The Be Seen Be Heard Global Youth Survey
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230108005001/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting tilføjer House of Code for at styrke teknologi- og dataløsninger26.6.2026 20:01:00 CEST | Pressemeddelelse
Andersen Consulting forstærker sine kompetencer inden for teknologisk transformation gennem en samarbejdsaftale med House of Code, en global virksomhed med hovedkvarter i USA, der specialiserer sig i datadrevne platforme, automatisering og agentbaserede ai-løsninger. House of Code blev stiftet i 2001 og udvikler softwareløsninger samt yder rådgivning til energihandels- og finanssektoren med kunder, der spænder over hedgefonde, kapitalfonde og forsyningsvirksomheder. Virksomheden besidder dyb ekspertise inden for energihandel og risikostyring og hjælper organisationer med systemimplementering, forretningstransformation, dataautomatisering og ai-underbygget modernisering af arbejdsgange. Deres proprietære platform, Enterprise Platform for Integrated Compliance (EPIC), skaber en mere effektiv datastyring, automatiserer rapporteringsprocesser, forbedrer den driftsmæssige gennemsigtighed på tværs af virksomhedssystemer og skaber et fundament for opbygning af intelligente, agentbaserede arbe
Capco Recognized by OpenAI for Innovation and Responsible AI Leadership26.6.2026 20:00:00 CEST | Press release
Receives AI Governance & Risk Excellence Award at OpenAI Partner SummitCapco’s UK AI Lab wins OpenAI Codex Hackathon Global management and technology consultancy Capco, a Wipro company,has been recognized by OpenAI for both AI innovation and responsible AI leadership. Capco received the AI Governance & Risk Excellence Award at the recent OpenAI Partner Summit 2026 in San Francisco, highlighting Capco’s ability to deliver enterprise-grade AI outcomes in highly regulated environments. The award recognizes Capco’s expert advantage when helping financial services and energy organizations to scale AI with confidence, balancing innovation with strong governance to reduce risk, strengthen compliance and improve customer outcomes. This award follows Capco winning the OpenAI Codex Hackathon, where its UK AI Lab competed against more than 30 teams and over 100 participants from across the OpenAI partner ecosystem. Capco's winning entry Sentra – a consulting-led, AI-powered retail banking solutio
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release
If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release
Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use
DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release
-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
